As shown in Table 4, NDUFA9 and UQCRQ levels decreased in the NAFLD group compared to control group, but there was no significant difference in NDUFB8 level between NAFLD patients and controls (P = 0.703337 > 0.05). This evidence concerns the gene NDUFA9 and metabolic dysfunction-associated steatotic liver disease.